The U. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’ therapy for a ‌rare form of obesity caused by ...
Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results